{"id":13192,"date":"2026-09-16T16:51:41","date_gmt":"2026-09-16T14:51:41","guid":{"rendered":"https:\/\/my-swiss-company.com\/?p=13192"},"modified":"2026-09-16T16:51:41","modified_gmt":"2026-09-16T14:51:41","slug":"start-pharmaceutical-company-switzerland","status":"publish","type":"post","link":"https:\/\/my-swiss-company.com\/en\/start-pharmaceutical-company-switzerland\/","title":{"rendered":"Starting a pharmaceutical company in Switzerland: three regimes, the Swissmedic establishment licence and the responsible person"},"content":{"rendered":"<div class=\"intro-box\">\n<p>Starting a pharmaceutical company in Switzerland does not mean applying for a single &#8220;pharma licence&#8221;. Three regimes coexist. A medicinal product requires a Swissmedic establishment licence, granted after an inspection and tied to a named responsible person. A medical device requires no licence at all, but a Swiss authorised representative and a registration number. A food supplement is a foodstuff: no authorisation, only a notification of the activity to the cantonal authority.<\/p>\n<p>The regime you fall under determines your entry cost, your organisation and the first person you need to hire. This guide follows the order in which these questions actually arise, with the articles of the Therapeutic Products Act, its ordinances and the Swissmedic fees in force since 1 July 2026.<\/p>\n<\/div>\n<div class=\"table-of-contents\">\n<h3>Contents<\/h3>\n<ol>\n<li><a href=\"#three-regimes\">Medicine, medical device, supplement: three regimes<\/a><\/li>\n<li><a href=\"#establishment-licence\">The Swissmedic establishment licence<\/a><\/li>\n<li><a href=\"#responsible-person\">The responsible person: the heart of the file<\/a><\/li>\n<li><a href=\"#costs\">What a pharmaceutical company costs in Switzerland<\/a><\/li>\n<li><a href=\"#trading\">Trading, brokerage and foreign trade from Switzerland<\/a><\/li>\n<li><a href=\"#medical-devices\">Medical devices: Swiss representative and CHRN<\/a><\/li>\n<li><a href=\"#supplements\">Food supplements: a foodstuff, not a medicine<\/a><\/li>\n<li><a href=\"#company\">Legal form, premises and innovation taxation<\/a><\/li>\n<li><a href=\"#pitfalls\">The pitfalls of a pharmaceutical project<\/a><\/li>\n<\/ol>\n<\/div>\n<h2 id=\"three-regimes\">Medicine, medical device, supplement: three regimes<\/h2>\n<p>The first decision when you start a pharmaceutical company in Switzerland is to classify your product, because the Therapeutic Products Act (TPA) treats differently what acts through a medicinal mechanism and what does not. A medicinal product is defined as a product of chemical or biological origin intended to act medically on the human or animal organism, or presented as such. A medical device is a product for medical use &#8220;whose principal action is not obtained by a medicinal product&#8221;: instruments, apparatus, software, implants, in vitro diagnostics.<\/p>\n<p>A food supplement falls outside the TPA. The Federal Food Safety and Veterinary Office defines it as a foodstuff that supplements a normal diet with vitamins, minerals or other substances having a nutritional or physiological effect. These three classifications determine the competent authority and the starting point of the project.<\/p>\n<div class=\"msc-table-wrap\">\n<table class=\"msc-table\">\n<caption class=\"msc-caption\">The three regimes for a health business in Switzerland<\/caption>\n<thead>\n<tr>\n<th>Product<\/th>\n<th>Authority<\/th>\n<th>Company authorisation<\/th>\n<th>Structural requirement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Medicinal product<\/td>\n<td>Swissmedic<\/td>\n<td>Establishment licence, granted after inspection<\/td>\n<td>Responsible person, quality assurance system<\/td>\n<\/tr>\n<tr>\n<td>Medical device<\/td>\n<td>Swissmedic<\/td>\n<td>No official authorisation<\/td>\n<td>Swiss authorised representative if the manufacturer is abroad, CHRN registration<\/td>\n<\/tr>\n<tr>\n<td>Food supplement<\/td>\n<td>Cantonal enforcement authority<\/td>\n<td>No authorisation, no product registration<\/td>\n<td>Notification of the activity, responsible person, self-monitoring<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>The border is crossed faster than founders expect. A supplement advertised as treating a disease is no longer a foodstuff in the eyes of the law, and software that helps establish a diagnosis may qualify as a medical device. Settle this question before incorporating: the wrong regime means the wrong structure.<\/p>\n<h2 id=\"establishment-licence\">The Swissmedic establishment licence<\/h2>\n<p>Any company that manufactures, imports, exports or wholesales medicinal products in Switzerland must hold an establishment licence issued by Swissmedic, the Swiss Agency for Therapeutic Products. Swissmedic states that the licence is granted &#8220;notamment sur la base d&#8217;une inspection&#8221;, and that, with few exceptions, it is issued for an unlimited duration.<\/p>\n<h3>Activities subject to a licence<\/h3>\n<ul>\n<li><strong>Manufacture<\/strong> of medicinal products (Art. 5 TPA), understood broadly: from sourcing raw materials to packaging the finished product, including storage, quality controls and batch release.<\/li>\n<li><strong>Import and export<\/strong> of medicinal products for distribution or dispensing (Art. 18(1)(a) and (b) TPA). Storage in a customs warehouse or a bonded warehouse counts as an import.<\/li>\n<li><strong>Foreign trade<\/strong> from Switzerland, where the goods never enter the country, and activity as a broker or agent (Art. 18(1)(c) and (d) TPA).<\/li>\n<li><strong>Wholesale trade<\/strong> (Art. 28 TPA).<\/li>\n<\/ul>\n<p>Dispensing medicines to the public, by contrast, is not a Swissmedic matter: &#8220;Quiconque remet des m\u00e9dicaments doit poss\u00e9der une autorisation cantonale&#8221; (Art. 30 TPA). Opening a pharmacy is therefore a separate cantonal project, not covered here.<\/p>\n<h3>The conditions<\/h3>\n<p>For each activity the law sets the same two conditions: that the requirements regarding professional qualifications and operations are met, and that an appropriate quality assurance system exists. The authority verifies compliance by inspection (Art. 6, 19 and 28 TPA).<\/p>\n<p>The Ordinance on Establishment Licences (OEL) spells out what this means for a manufacturer: an operational pharmaceutical quality assurance system with the active participation of management, enough qualified staff, a responsible person, premises designed and maintained to guarantee reliable manufacturing, a documentation system, validated processes and quality control that is independent from production (Art. 3 OEL). An importer must further show that the foreign manufacturer holds a licence from a country whose GMP control system Swissmedic considers equivalent (Art. 11 OEL).<\/p>\n<div class=\"important-box\">\n<h4>Important<\/h4>\n<p>None of these activities may start before the licence is granted. Swissmedic publishes no processing time: it depends on the completeness of the file and on the inspection, and the licence is granted only &#8220;if the application file is complete&#8221; (Art. 39 OEL). Where the classification of your activity is uncertain, contact Swissmedic or a specialised lawyer before signing with suppliers or customers.<\/p>\n<\/div>\n<h2 id=\"responsible-person\">The responsible person: the heart of the file<\/h2>\n<p>The responsible person exercises direct technical supervision of the establishment and answers for the quality of the medicinal products. That person, far more than the share capital or the legal form, determines whether the licence is granted, and is often the first hire of a Swiss pharmaceutical company.<\/p>\n<h3>Independence written into the ordinance<\/h3>\n<p>The responsible person may not sit on a supervisory body of the establishment and must decide on the release or rejection of manufacturing batches in full independence from management (Art. 5(6) and 17(6) OEL). Swissmedic may grant an exception to companies too small to separate these functions. Where the role is part-time, the responsibilities and the minimum presence in the establishment must be set out in writing.<\/p>\n<h3>Which qualification to require<\/h3>\n<ul>\n<li><strong>Manufacture of ready-to-use medicines<\/strong>: a pharmacist&#8217;s degree and the required experience (Art. 6(1)(a) OEL).<\/li>\n<li><strong>Active pharmaceutical ingredients<\/strong>: a university degree in science and the required experience (Art. 6(1)(c) OEL).<\/li>\n<li><strong>Import, export and wholesale<\/strong>: the necessary training, technical knowledge and experience (Art. 18(1) OEL). A pharmacist&#8217;s degree becomes mandatory where the company itself releases ready-to-use medicines onto the Swiss market as marketing authorisation holder, or has medicines manufactured or tested by a third party (Art. 18(2) and Art. 12 OEL).<\/li>\n<\/ul>\n<p>Swissmedic may recognise other qualifications where the person can demonstrate sufficient knowledge and experience.<\/p>\n<div class=\"conseil-msc\">\n<h4>My Swiss Company advice<\/h4>\n<p>Hire or contract the responsible person before filing the application, and document from the start the minimum presence, the deputising arrangements and the independence from management. The licence names the responsible person, the authorised activities and the site (Art. 40 OEL): that person leaving is not an ordinary staff movement, it is a change to the licence that must be notified.<\/p>\n<\/div>\n<h2 id=\"costs\">What a pharmaceutical company costs in Switzerland<\/h2>\n<p>Swissmedic fees are modest compared with the project as a whole; the real cost sits in the premises, the quality system and the responsible person. The Swissmedic Fees Ordinance sets the following amounts for establishment licences.<\/p>\n<div class=\"msc-table-wrap\">\n<table class=\"msc-table\">\n<caption class=\"msc-caption\">Swissmedic fees for establishment licences (Fees Ordinance, Annex 1)<\/caption>\n<thead>\n<tr>\n<th>Service<\/th>\n<th>Amount<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Grant of an establishment licence<\/td>\n<td>CHF 1,500<\/td>\n<\/tr>\n<tr>\n<td>Amendment of a licence<\/td>\n<td>CHF 600<\/td>\n<\/tr>\n<tr>\n<td>Assessment of inspection reports from regional inspectorates<\/td>\n<td>CHF 200<\/td>\n<\/tr>\n<tr>\n<td>Database update<\/td>\n<td>CHF 100<\/td>\n<\/tr>\n<tr>\n<td>Basic certificate for an establishment licence, per site<\/td>\n<td>CHF 200<\/td>\n<\/tr>\n<tr>\n<td>Services charged by time spent<\/td>\n<td>CHF 270 per hour<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>The hourly rate of CHF 270 has applied since 1 July 2026, and Swissmedic may charge a surcharge where the documentation of an application is incomplete. Amendments to a licence are subject to an application on which Swissmedic decides within 30 days (Art. 41 OEL); that deadline does not apply to the initial grant.<\/p>\n<p>Beyond the fees, budget for the salary or mandate of the responsible person, bringing the premises into line with good manufacturing or distribution practice, drafting the documentation system, and the working capital needed to operate while the file is being processed, without revenue.<\/p>\n<div class=\"msc-cta-inline\">\n<p class=\"msc-cta-kicker\">Your pharmaceutical company in Switzerland<\/p>\n<p class=\"msc-cta-title\">The regime first, the company second<\/p>\n<p>Classifying the product and the activity, choosing the legal form and drafting the corporate purpose, incorporation, coordination with your responsible person and your regulatory advisers, then accounting, VAT and payroll: My Swiss Company structures your company in the order Swissmedic expects, from Geneva, Lucerne or Zug.<\/p>\n<p>    <a class=\"msc-cta-btn\" href=\"https:\/\/my-swiss-company.com\/en\/contact\/\" target=\"_blank\" rel=\"noopener\">Scope your project<\/a><br \/>\n    <span class=\"msc-cta-note\">Swiss Corporate Services Provider in Geneva, Lucerne and Zug, serving clients in more than 20 countries.<\/span>\n<\/div>\n<h2 id=\"trading\">Trading, brokerage and foreign trade from Switzerland<\/h2>\n<p>A Swiss company that buys and resells medicines without them ever entering Switzerland carries on foreign trade, which requires a licence just as importing does (Art. 18(1)(c) TPA). A broker or agent who connects suppliers and buyers from Switzerland also needs a licence (Art. 18(1)(d) TPA).<\/p>\n<p>For brokerage and agency activity, the ordinance requires an operational quality assurance system, a responsible person who decides independently from management, an appropriate organisation and a documentation system (Art. 24 and 26 OEL). The licence holder must ensure that the supplier and the recipient are themselves authorised, and be able to produce evidence of this, and that the medicines do not come from illegal trade (Art. 25 OEL). A brokerage licence &#8220;does not confer the right to award manufacturing contracts&#8221; (Art. 24(3) OEL).<\/p>\n<p>One point deserves a clear warning, because offers of Swiss companies &#8220;already licensed&#8221; do circulate. The licence is &#8220;intransmissible \u00e0 d&#8217;autres personnes ou \u00e0 d&#8217;autres sites&#8221; (Art. 40 OEL), it names a responsible person and a specific site, and Swissmedic may revoke it where no licensed activity has been carried out for more than twelve months (Art. 42 OEL). Buying a shell exempts you from neither the responsible person, nor the organisation, nor the inspections.<\/p>\n<h2 id=\"medical-devices\">Medical devices: Swiss representative and CHRN<\/h2>\n<p>A medical device company needs no establishment licence: Swissmedic puts it plainly, &#8220;contrairement aux m\u00e9dicaments, les dispositifs m\u00e9dicaux ne sont soumis \u00e0 aucune autorisation officielle&#8221;. The obligations fall on the economic operators in the chain.<\/p>\n<ul>\n<li><strong>The Swiss authorised representative<\/strong>: where the manufacturer has no registered office in Switzerland, its devices may only be placed on the market if it has appointed a representative established in Switzerland, under a written mandate (Art. 51 MedDO). Swissmedic requires the representative&#8217;s name and address to appear in the immediate vicinity of the CH-REP symbol; a post office box, an email address or a telephone number is not sufficient.<\/li>\n<li><strong>The importer<\/strong> verifies, before placing a device on the market, the conformity marking, the declaration of conformity, the identification of the manufacturer and its representative, the labelling and the unique device identifier, and states its own name and address on the device or its packaging (Art. 53 MedDO).<\/li>\n<li><strong>The distributor<\/strong> acts with due care and carries out equivalent checks, which may be done by sampling (Art. 54 MedDO).<\/li>\n<li><strong>Registration<\/strong>: before the first placing on the market, manufacturers, representatives and importers register with Swissmedic, which assigns a Swiss single registration number (CHRN); any change of data must be notified within one week (Art. 55 MedDO).<\/li>\n<\/ul>\n<p>For a manufacturer established in the European Union, a Swiss company can therefore act as authorised representative, as importer, or as both, provided it genuinely assumes the obligations attached to those roles.<\/p>\n<h2 id=\"supplements\">Food supplements: a foodstuff, not a medicine<\/h2>\n<p>Placing a food supplement on the Swiss market requires no authorisation: the Federal Food Safety and Veterinary Office states that notification of food supplements is not necessary in Switzerland. The company is not, however, free of obligations.<\/p>\n<ul>\n<li>It notifies its activity: anyone carrying on an activity involving the handling of foodstuffs must notify that activity to the competent cantonal enforcement authority (Art. 20 FSGO).<\/li>\n<li>It appoints a responsible person with a business address in Switzerland, who ensures self-monitoring at every stage (Art. 73 and 74 FSGO).<\/li>\n<li>It complies with the maximum quantities of vitamins and minerals set by the ordinance on food supplements and uses only health claims listed in the relevant annex or authorised by the office.<\/li>\n<\/ul>\n<p>The limit is set by the office itself: food supplements must have no pharmacological effect, must not be presented as medicines and must not carry claims that they cure, alleviate or prevent diseases. A therapeutic claim moves the product, and the company, into the medicinal regime.<\/p>\n<h2 id=\"company\">Legal form, premises and innovation taxation<\/h2>\n<p>No legal form is imposed, but the public limited company is often required once investors come in, while the limited liability company remains suitable for a distribution or representative business. The incorporation steps are those of any Swiss company, set out in our guide to the <a href=\"https:\/\/my-swiss-company.com\/en\/incorporation-of-a-company-in-switzerland\/\">incorporation of a company in Switzerland<\/a>. What sets a pharmaceutical project apart is substance: the licence names a site, and that site is inspected.<\/p>\n<p>Production premises deserve particular attention. The Labour Act makes prior approval of plans by the cantonal authority mandatory not only for industrial undertakings, but also, among others, for chemical and technical production plants and for businesses using microorganisms of groups 3 or 4 (Art. 1(2) Ordinance 4 to the Labour Act). That procedure runs before the fit-out works, in parallel with the Swissmedic file.<\/p>\n<p>On the tax side, cantons may grant an additional deduction of up to 50% of research and development expenditure, and a reduction of up to 90% on profit from patents (patent box), with total relief capped at 70% of taxable profit. The rates vary widely: 90% patent box relief in Zurich, Zug, Lucerne and Basel-Stadt, 60% in the canton of Vaud, 10% in Geneva. We set out these mechanisms in our guide to <a href=\"https:\/\/my-swiss-company.com\/en\/start-saas-company-switzerland\/\">starting a SaaS company in Switzerland<\/a>, and the bookkeeping they require is part of our <a href=\"https:\/\/my-swiss-company.com\/en\/our-services\/administration-services-for-swiss-companies\/\">administration services for Swiss companies<\/a>.<\/p>\n<h2 id=\"pitfalls\">The pitfalls of a pharmaceutical project<\/h2>\n<p>The first pitfall is classifying the product too late: a supplement brand that communicates therapeutic effects, or health software launched without analysing its status, ends up in a regime the company is not organised for.<\/p>\n<p>The second is a responsible person on paper only: a name on the file, with no written minimum presence, no deputy, or sitting on a supervisory body of the company. An inspection will see it, and the independence required by the ordinance is not negotiable.<\/p>\n<p>The third is the company &#8220;with a licence&#8221; that is bought or left dormant: the licence is non-transferable, attached to a site and a person, and revocable after twelve months without activity.<\/p>\n<p>The fourth concerns medtech: placing a foreign manufacturer&#8217;s devices on the Swiss market without a written mandate or CHRN registration, or with a mere post office box on the label.<\/p>\n<p>The fifth is confusing the tiers of the chain: dispensing to the public is cantonal, wholesale and import are Swissmedic matters, and one licence does not carry the other.<\/p>\n<section id=\"faq\">\n<h2>FAQ: starting a pharmaceutical company in Switzerland<\/h2>\n<div class=\"question\">\n<h3>Do you need a licence to start a pharmaceutical company in Switzerland?<\/h3>\n<p>Incorporating the company requires no licence, but any activity of manufacturing, importing, exporting, wholesaling, foreign trading or brokering medicinal products requires a Swissmedic establishment licence (Art. 5, 18 and 28 TPA). It is granted where the requirements on professional qualifications and operations are met and an appropriate quality assurance system exists, verified by inspection. Medical devices and food supplements are not subject to that licence.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>How much does a Swissmedic establishment licence cost?<\/h3>\n<p>The grant costs CHF 1,500, an amendment CHF 600, assessment of inspection reports from regional inspectorates CHF 200 and a database update CHF 100, under the Swissmedic Fees Ordinance. Services charged by time spent are billed at CHF 270 per hour since 1 July 2026. The main cost of a project remains the responsible person, the premises and the quality assurance system.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Must the responsible person be a pharmacist?<\/h3>\n<p>For the manufacture of ready-to-use medicines, yes: the ordinance requires a pharmacist&#8217;s degree and the necessary experience. For import and wholesale, the person must have the required training, knowledge and experience, and a pharmacist&#8217;s degree becomes mandatory where the company itself releases medicines onto the Swiss market or has them manufactured by a third party. Swissmedic may recognise other qualifications supported by sufficient experience.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>How long is a Swissmedic licence valid?<\/h3>\n<p>With few exceptions, Swissmedic issues establishment licences for an unlimited duration. Periodic inspections verify that the conditions are still met, and Swissmedic may revoke the licence in whole or in part if they are not, or if no licensed activity has been carried out for more than twelve months (Art. 42 OEL).<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Does a medical device company need an authorisation?<\/h3>\n<p>No, medical devices are not subject to any official authorisation. A manufacturer without a registered office in Switzerland must, however, appoint a Swiss authorised representative in writing (Art. 51 MedDO), and manufacturers, representatives and importers register with Swissmedic, which assigns a CHRN, before the first placing on the market (Art. 55 MedDO).<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Can food supplements be sold in Switzerland without authorisation?<\/h3>\n<p>Yes, the product requires neither authorisation nor notification. The company does, however, notify its activity to the cantonal enforcement authority, appoints a responsible person with a business address in Switzerland and carries out self-monitoring. The product must have no pharmacological effect and must not be presented as curing, alleviating or preventing a disease.<\/p>\n<\/p><\/div>\n<\/section>\n<section id=\"sources\">\n<h2>Sources<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2001\/422\/fr\" target=\"_blank\" rel=\"noopener\">Federal Act on Medicinal Products and Medical Devices (TPA, SR 812.21), Art. 4, 5, 6, 18, 19, 28 and 30<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2018\/786\/fr\" target=\"_blank\" rel=\"noopener\">Ordinance on Establishment Licences (OEL, SR 812.212.1), Art. 3 to 6, 11 to 13, 17, 18, 24 to 26, 39 to 42<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2018\/593\/fr\" target=\"_blank\" rel=\"noopener\">Swissmedic Fees Ordinance (SR 812.214.5), Art. 4 and Annex 1<\/a><\/li>\n<li><a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/humanarzneimittel\/bewilligungen_zertifikate\/betriebsbewilligungen.html\" target=\"_blank\" rel=\"noopener\">Swissmedic, Establishment licences<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2020\/552\/fr\" target=\"_blank\" rel=\"noopener\">Medical Devices Ordinance (MedDO, SR 812.213), Art. 51, 53, 54 and 55<\/a><\/li>\n<li><a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/medical-devices\/market-access\/ch-rep.html\" target=\"_blank\" rel=\"noopener\">Swissmedic, Swiss authorised representative (CH-REP)<\/a><\/li>\n<li><a href=\"https:\/\/www.blv.admin.ch\/en\/food-supplements\" target=\"_blank\" rel=\"noopener\">Federal Food Safety and Veterinary Office, Food supplements<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2017\/63\/fr\" target=\"_blank\" rel=\"noopener\">Foodstuffs and Utility Articles Ordinance (FSGO, SR 817.02), Art. 20, 73 and 74<\/a><\/li>\n<\/ul>\n<\/section>\n<div class=\"conclusion-box\">\n<h2>Conclusion<\/h2>\n<p>Starting a pharmaceutical company in Switzerland begins with a classification, not with articles of association. A medicinal product means a Swissmedic establishment licence, a responsible person independent from management and a quality system verified on site. A medical device means a representative and a registration. A food supplement means a notification and self-monitoring. The fees are known and reasonable, but the timetable depends on the completeness of the file, and the licence remains tied to a person, to activities and to a site.<\/p>\n<p>My Swiss Company SA is a Swiss Corporate Services Provider in Geneva, Lucerne and Zug, serving clients in more than 20 countries through its <a href=\"https:\/\/my-swiss-company.com\/en\/our-services\/swiss-company-formation-services\/\">Swiss company formation services<\/a>. We structure the incorporation in line with the regulatory regime you choose, then handle accounting, VAT and payroll. To scope your project, <a href=\"https:\/\/my-swiss-company.com\/en\/contact\/\">let&#8217;s talk<\/a>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Starting a pharmaceutical company in Switzerland does not mean applying for a single &#8220;pharma licence&#8221;. Three regimes coexist. A medicinal product requires a Swissmedic establishment licence, granted after an inspection and tied to a named responsible person. A medical device requires no licence at all, but a Swiss authorised representative and a registration number. A [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":13205,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[30,9],"tags":[],"class_list":["post-13192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-formation","category-creation-dentreprise"],"rank_math":{"rank_math_title":"Start a Pharmaceutical Company in Switzerland: Swissmedic Licence","rank_math_description":"Start a pharmaceutical company in Switzerland: Swissmedic establishment licence, responsible person, CHF 1,500 fee, CH-REP for medical devices.","rank_math_focus_keyword":"start a pharmaceutical company in switzerland"},"_links":{"self":[{"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/posts\/13192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/comments?post=13192"}],"version-history":[{"count":2,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/posts\/13192\/revisions"}],"predecessor-version":[{"id":13196,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/posts\/13192\/revisions\/13196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/media\/13205"}],"wp:attachment":[{"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/media?parent=13192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/categories?post=13192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/my-swiss-company.com\/en\/wp-json\/wp\/v2\/tags?post=13192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}